Log in

LON:CREO - Creo Medical Group Share Price, Forecast & News

GBX 172.50
-1.00 (-0.58 %)
(As of 02/23/2020 04:00 PM ET)
Today's Range
Now: GBX 172.50
50-Day Range
MA: GBX 175.65
52-Week Range
Now: GBX 172.50
Volume3,400 shs
Average Volume16,051 shs
Market Capitalization£259.58 million
P/E RatioN/A
Dividend YieldN/A
Creo Medical Limited develops and sells instruments for surgical endoscopy in the United Kingdom. The company is developing instruments for endoscopy through a combination of bipolar radiofrequency and microwave energy in a single platform for tissue dissection, resection, ablation, and coagulation. It offers Speedboat RS2 instrument for endoscopic submucosal dissection. Creo Medical Limited was formerly known as MicroOncology Ltd. The company was founded in 2003 and is based in Chepstow, the United Kingdom. Creo Medical Limited is a subsidiary of Creo Medical Group plc.

Industry, Sector and Symbol

Industry Medical Devices



Sales & Book Value

Annual Sales£7,699.00
Price / Sales33,716.70
Cash FlowGBX 31.71 per share
Book ValueGBX 33.40 per share



Market Cap£259.58 million
Next Earnings DateN/A
OptionableNot Optionable

Receive CREO News and Ratings via Email

Sign-up to receive the latest news and ratings for CREO and its competitors with MarketBeat's FREE daily newsletter.

Creo Medical Group (LON:CREO) Frequently Asked Questions

What is Creo Medical Group's stock symbol?

Creo Medical Group trades on the London Stock Exchange (LON) under the ticker symbol "CREO."

How were Creo Medical Group's earnings last quarter?

Creo Medical Group PLC (LON:CREO) released its quarterly earnings results on Tuesday, March, 20th. The company reported ($5.00) earnings per share (EPS) for the quarter. View Creo Medical Group's Earnings History.

Has Creo Medical Group been receiving favorable news coverage?

Headlines about CREO stock have been trending very positive this week, according to InfoTrie. The research group identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Creo Medical Group earned a daily sentiment score of 4.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for Creo Medical Group.

Who are some of Creo Medical Group's key competitors?

What other stocks do shareholders of Creo Medical Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Creo Medical Group investors own include Mysquare (MYSQ) and IQE (IQE).

Who are Creo Medical Group's key executives?

Creo Medical Group's management team includes the folowing people:
  • Mr. Craig Jonathan Gulliford, CEO & Director (Age 48)
  • Prof. Christopher Paul Hancock, Founder, CTO & Director (Age 51)
  • Mr. Richard John Rees ACA, CFO, Company Sec. & Director (Age 42)
  • Mr. Phil Hales, Sales & Marketing Director

How do I buy shares of Creo Medical Group?

Shares of CREO and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Creo Medical Group's stock price today?

One share of CREO stock can currently be purchased for approximately GBX 172.50.

How big of a company is Creo Medical Group?

Creo Medical Group has a market capitalization of £259.58 million and generates £7,699.00 in revenue each year. Creo Medical Group employs 50 workers across the globe.View Additional Information About Creo Medical Group.

What is Creo Medical Group's official website?

The official website for Creo Medical Group is http://creomedical.com/.

How can I contact Creo Medical Group?

The company can be reached via phone at +44-1291-606005.

MarketBeat Community Rating for Creo Medical Group (LON CREO)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  104 (Vote Outperform)
Underperform Votes:  102 (Vote Underperform)
Total Votes:  206
MarketBeat's community ratings are surveys of what our community members think about Creo Medical Group and other stocks. Vote "Outperform" if you believe CREO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CREO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Featured Article: Risk Tolerance

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel